Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -5.80 (-5.32%)
Bid:
103.00
Ask:
104.20
Spread: 1.20 (1.165%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

AGM & Interim Management Statement

14 May 2009 07:00

RNS Number : 1992S
Yule Catto & Co PLC
14 May 2009
 

14 May 2009

Yule Catto & Co plc 

AGM and Interim Management Statement

At today's Annual General Meeting of Yule Catto & Co plc, an international producer of speciality chemicals, Peter Wood, Chairman, will make the following statement, which comprises Yule Catto's Interim Management Statement for the period from 1 January 2009 to date.

Trading update

2009 has started satisfactorily given the very difficult macro economic environment. The Group has benefited from the weakness of sterling, and overall the Group has traded in line with management expectations.

In Polymer Chemicals, the substantial volume declines seen in the fourth quarter of 2008 persisted into 2009 although March was slightly better than the first two months of the year.

Pharma Chemicals had a good first quarter compared to what was a relatively weak start to 2008. Profits were in line with our expectations for a stronger full year performance in 2009. 

William Blythe, the remaining Impact Chemicals business was ahead of last year as expected, and benefited from the restructuring implemented at the end of the first quarter of 2008.

The Group announced a number of cost reduction initiatives with its full year 2008 results which are on track.

Following the successful refinancing at the year end with a new revolving finance facility and Malaysian term loan, the Group is making good progress on its debt reduction target. 

Looking forward we continue to expect the Pharma business to deliver higher profits than 2008, assisted by the favourable €/$ exchange rate and increased capacities for a number of products. Similarly William Blythe should continue to trade satisfactorily following its restructuring. Volume declines in Polymers moderated at the end of the first quarter but the outlook for the balance of the year remains uncertain. A large proportion of the Polymer Division's sales are in Europe and Asia and hence we are currently benefiting from the weakness of sterling. Given the uncertainty in our end markets, it is difficult to give any firm guidance on the outturn for Polymers for the full year and hence the Group as a whole.

Board Changes

Further to the retirement of Anthony Richmond-Watson, two other non executive directors will be retiring at this Annual General Meeting:- Dato' Seri Lee Oi Hian, who joined the Board in 1981 and is Chief Executive of Kuala Lumpur Kepong Bhd which has been a major shareholder in the Company since 1976; and Richard Hunting, an independent non executive director, who joined the Board in 2000 and has been Chairman of the Nomination Committee since 2001 and a member of the Audit Committee for nine years. I would like to thank all of them for their valuable contribution to the Group.

We are delighted to welcome Graham Menzies who joined the Board on 1 March this year. Graham's biographical details are in the circular that accompanied the 2008 Annual Report and he has been appointed as the Senior Independent Director after a distinguished career as a public company chief executive.

These changes complete the realignment of our Board structure and we believe that the Board, as currently constituted, is appropriate and balanced to serve the future needs of the Group.

ENQUIRIES:

YULE CATTO & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive 

David Blackwood, Finance Director 

 

HOGARTH PARTNERSHIP

Tel: 020 7357 9477

John Olsen

Andrew Jaques

Ian Payne

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSAJMATMMBBBBL
Date   Source Headline
2nd Jan 20259:00 amRNSDirectorate Change
31st Oct 20247:00 amRNSTrading statement - Autumn 2024
17th Oct 20244:01 pmRNSHolding(s) in Company
14th Oct 20241:51 pmRNSHolding(s) in Company
27th Sep 202412:46 pmRNSHolding(s) in Company
19th Sep 20241:01 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSInterim results
18th Jul 202412:53 pmRNSChair succession and other board changes
17th May 20248:20 amRNSPost Stabilisation Notice
9th May 20242:29 pmRNSResults of AGM
9th May 20247:00 amRNSTrading Statement - Spring 2024
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
9th Oct 20233:08 pmRNSHolding(s) in Company
9th Oct 20239:44 amRNSHolding(s) in Company
6th Oct 20231:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.